220 related articles for article (PubMed ID: 19289296)
1. Adalimumab-induced neutropenia in a patient with rheumatoid arthritis.
Ottaviani S; Cerf-Payrastre I; Kemiche F; Pertuiset E
Joint Bone Spine; 2009 May; 76(3):312-3. PubMed ID: 19289296
[No Abstract] [Full Text] [Related]
2. A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C.
Chen YM; Chen HH; Chen YH; Hsieh TY; Hsieh CW; Hung WT; Lan JL; Chen DY
Ann Rheum Dis; 2015 Mar; 74(3):626-7. PubMed ID: 25452310
[No Abstract] [Full Text] [Related]
3. Efficacy of rituximab on pulmonary nodulosis occurring or increasing in patients with rheumatoid arthritis during anti-TNF-α therapy.
De Stefano R; Frati E; Nargi F; Menza L
Clin Exp Rheumatol; 2011; 29(4):752-3. PubMed ID: 21906436
[No Abstract] [Full Text] [Related]
4. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
Nagashima T; Minota S
J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
[No Abstract] [Full Text] [Related]
5. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
[No Abstract] [Full Text] [Related]
6. Appearance of rheumatoid nodules following anti-tumor necrosis factor alpha treatment with adalimumab for rheumatoid arthritis.
Scrivo R; Spadaro A; Iagnocco A; Valesini G
Clin Exp Rheumatol; 2007; 25(1):117. PubMed ID: 17418005
[No Abstract] [Full Text] [Related]
7. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).
Chaves Y; Duarte G; Ben-Said B; Tebib J; Berard F; Nicolas JF
Dermatology; 2008; 217(4):380. PubMed ID: 18849606
[No Abstract] [Full Text] [Related]
8. Kaposi's disease in a patient on adalimumab for rheumatoid arthritis.
Bret J; Hernandez J; Aquilina C; Zabraniecki L; Fournie B
Joint Bone Spine; 2009 Dec; 76(6):721-2. PubMed ID: 19945327
[No Abstract] [Full Text] [Related]
9. Pyoderma gangrenosum in a patient with seronegative rheumatoid arthritis during therapy with adalimumab: toxic effects of adalimumab or failure of adalimumab to prevent the onset of this phenomenon?
Stichenwirth M; Riedl E; Pehamberger H; Tappeiner G
Arch Dermatol; 2008 Jun; 144(6):817-8. PubMed ID: 18559788
[No Abstract] [Full Text] [Related]
10. Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumab.
Boura P; Sarantopoulos A; Lefaki I; Skendros P; Papadopoulos P
Ann Rheum Dis; 2006 Jun; 65(6):839-40. PubMed ID: 16699060
[No Abstract] [Full Text] [Related]
11. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA
Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698
[No Abstract] [Full Text] [Related]
12. Mycobacterium chelonae infection associated with adalimumab therapy.
Díaz F; Urkijo JC; Mendoza F; de la Viuda JM; Blanco M; Unzurrunzaga A; Ayarza R
Scand J Rheumatol; 2008; 37(2):159-60. PubMed ID: 18415777
[No Abstract] [Full Text] [Related]
13. Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma.
Liozon E; Ouattara B; Loustaud-Ratti V; Vidal E
Scand J Rheumatol; 2007; 36(6):484-6. PubMed ID: 18092275
[No Abstract] [Full Text] [Related]
14. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Hochman D; Wolff B
JAMA; 2006 Nov; 296(18):2203; author reply 2203-4. PubMed ID: 17090763
[No Abstract] [Full Text] [Related]
15. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Callegari PE; Schaible TF; Boscia JA
JAMA; 2006 Nov; 296(18):2202; author reply 2203-4. PubMed ID: 17090762
[No Abstract] [Full Text] [Related]
16. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
Costenbader KH; Glass R; Cui J; Shadick N
JAMA; 2006 Nov; 296(18):2201; author reply 2203-4. PubMed ID: 17090761
[No Abstract] [Full Text] [Related]
17. Adalimumab-induced asthma.
Bennett AN; Wong M; Zain A; Panayi G; Kirkham B
Rheumatology (Oxford); 2005 Sep; 44(9):1199-200. PubMed ID: 15870147
[No Abstract] [Full Text] [Related]
18. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
[TBL] [Abstract][Full Text] [Related]
19. Disseminated histoplasmosis associated with the treatment of rheumatoid arthritis with anticytokine therapy.
Asrani NS
Ann Intern Med; 2008 Oct; 149(8):594-5. PubMed ID: 18936512
[No Abstract] [Full Text] [Related]
20. Miller-Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab.
Kurmann PT; Van Linthoudt D; So AK
Clin Rheumatol; 2009 Jan; 28(1):93-4. PubMed ID: 18818868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
